Plasmepsin: Difference between revisions

From Proteopedia
Jump to navigationJump to search
Michal Harel (talk | contribs)
No edit summary
Michal Harel (talk | contribs)
No edit summary
Line 1: Line 1:
{{STRUCTURE_3fns| right| PDB=3fns  |  SCENE= |CAPTION=Plasmepsin dimer witn Zn+2 ions (grey), [[3fns]] }}
{{STRUCTURE_3fns| right| PDB=3fns  |  SCENE= |CAPTION=Plasmepsin dimer witn Zn+2 ions (grey), [[3fns]] }}
[[Plasmepsin]] (Plm) is a hemoglobin-degrading enzyme produced by the plasmodium parasite.  It is a potential target for anti-malaria drugs.  It is an aspartic acid protease having 2 aspartic acid residues in the active site.  Ten Plm isoforms are known which are named Plm I, II, etc and '''Histo-Aspartic Protease (HAP)'''.  '''ProPml II''' exhibits a large shift between its domains which renders the protease inactive.  The images on the left and right  correspond to one representative Plm structure, ''i.e.'' the Plasmepsin from ''Plasmodium falciparum'' ([[3fns]]).
[[Plasmepsin]] (Plm) is a hemoglobin-degrading enzyme produced by the plasmodium parasite.  It is a potential target for anti-malaria drugs.  It is an aspartic acid protease having 2 aspartic acid residues in the active site.  Ten Plm isoforms are known which are named Plm I, II, etc and '''Histo-Aspartic Protease (HAP)'''.  '''ProPml II''' exhibits a large shift between its domains which renders the protease inactive.   


<br />
<br />

Revision as of 08:50, 2 September 2014

Template:STRUCTURE 3fns Plasmepsin (Plm) is a hemoglobin-degrading enzyme produced by the plasmodium parasite. It is a potential target for anti-malaria drugs. It is an aspartic acid protease having 2 aspartic acid residues in the active site. Ten Plm isoforms are known which are named Plm I, II, etc and Histo-Aspartic Protease (HAP). ProPml II exhibits a large shift between its domains which renders the protease inactive.


3D structures of plasmepsin

Updated: 02-09-2014 (DD-MM-YYYY)

HAP

3fns – PfHAP - Plasmodium falciparum
3fnt – PfHAP + inhibitor pepstatin
3fnu – PfHAP + KNI-10006

Plm I

3qrv – PfPlm I residues 117-457
3qs1 - PfPlm I residues 117-457 + inhibitor

Plm II

1lf4 – PfPlm II
3f9q – PfPlm II (mutant)
2r9b – PfPlm II + peptide inhibitor
1w6h, 2bju, 1lf2, 1lf3, 1lee, 2igx, 2igy – PfPlm II + inhibitor
1w6i, 1xdh, 1xe5, 1xe6, 1me6, 1sme – PfPlm II + pepstatin derivative
1m43 - PfPlm II (mutant) + pepstatin derivative

ProPlm II

1pfz - PfProPlm II
1miq – PvProPlm II – Plasmodium vivax
1qs8 - PvPlm + pepstatin derivative

Plm IV

2anl – Plm IV + statine derivative – Plasmodium malariae
1ls5 - PfPlm IV + pepstatin derivative

Proteopedia Page Contributors and Editors (what is this?)

Alexander Berchansky, Michal Harel, Joel L. Sussman, Jaime Prilusky